Vaccine News and Research

Latest Vaccine News and Research

American Lung Association kicks off its Faces of Influenza campaign in Miami

The American Lung Association of Florida-South Area is kicking off its 2009-2010 Faces of Influenza initiative by conducting a public influenza panel discussion to help Miami area residents understand the seriousness of seasonal influenza and the importance of annual vaccination. The meeting will address the latest flu statistics and benefits of vaccination, especially among high-risk groups.

3 Oct 2009

HSPH's survey on H1N1 vaccines

In a new survey, Harvard School of Public Health (HSPH) researchers found that just 40% of adults are "absolutely certain" they will get the H1N1 vaccine for themselves, and 51% of parents are "absolutely certain" that they will get the vaccine for their children. The survey examined the reasoning among those who said they would not get the vaccine or might not. This is the latest in a series of surveys of public views concerning the H1N1 flu outbreak undertaken by the Harvard Opinion Research Program at HSPH. The polling was done September 14-20, 2009.

3 Oct 2009

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

In response to the shortage of Tamiflu in liquid form, all 795 Publix Pharmacies will offer to compound Tamiflu into an oral suspension.

3 Oct 2009

Surgical masks appear as effective as N95 respirators against influenza: Study

A McMaster University study has found that surgical masks appear to be as good as N95 respirators in protecting health-care workers against influenza.

3 Oct 2009

Chinese government places second purchase order for Sinovac Biotech's H1N1 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that Sinovac has received its second purchase order for its H1N1 vaccine, PANFLU.1, from the Ministry of Industry and Information Technology of the People's Republic of China for the national stockpiling plan.

3 Oct 2009

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

The optimal way to control swine flu, the new H1N1 virus that emerged as a global threat in 2009, is to vaccinate children with the planned H1N1 flu vaccine, says the co-director of the University of Alabama at Birmingham (UAB) Division of Pediatric Infectious Diseases.

3 Oct 2009

90% of public support H1N1 vaccination for health care workers

As H1N1 influenza vaccine begins to be shipped across the country, the Centers for Disease Control and Prevention emphasize getting the first doses to high-priority groups. One such group is health care workers.

3 Oct 2009

DelSite's assests acquired by Nanotherapeutics

Nanotherapeutics, Inc., a privately held specialty biopharmaceutical company, announced today that it had acquired certain assets from DelSite (formerly Carrington Laboratories, Inc.) out of Chapter 7 bankruptcy proceedings in the U.S. Bankruptcy Court for the Northern District of Texas, Dallas Division.

3 Oct 2009

Face mask: A vital tool in fighting H1N1

With flu season officially underway on October 4th, Cantel Medical Corp., a company dedicated to infection prevention and control, recommends that Americans take extra precautions against spreading H1N1 influenza. Crosstex International, a subsidiary of Cantel Medical, is one of the largest U.S. manufacturers of face masks.

3 Oct 2009

Interim results of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine clinical trials announced

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today an interim analysis of data from clinical trials of the U.S. licensed Influenza A (H1N1) 2009 Monovalent Vaccine in adults 18 years through 64 years of age and over the age of 65 years.

3 Oct 2009

Researchers screen decades-old frozen infant stool samples to detect norovirus

A search through decades-old frozen infant stool samples has yielded rich dividends for scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

3 Oct 2009

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

Baxter International Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) granted its “positive opinion” for CELVAPAN H1N1 pandemic vaccine using Baxter’s Vero cell technology. This positive opinion confirms the acceptability of Baxter’s regulatory submission to obtain final marketing authorization and licensure of the product.

From Baxter International Inc. 3 Oct 2009

First U.S. patients could receive H1N1 vaccine next week

U.S. health officials announced Thursday the first batches of the H1N1 (swine flu) vaccine the government ordered will begin arriving in designated locations across the country on Tuesday and may be administered in the first patients by the end of next week, Reuters reports (Fox, 10/1).

3 Oct 2009

Also in Global Health news: U.S. food aid declines; agriculture in Zimbabwe; U.S.-backed ITN network; reducing maternal mortality; DNDI expands; healthcare in Congo

Although U.S. food aid funding has increased by 53 percent over the last two years, a Government Accountability Office report on Wednesday said that during the same time period, the "amount of food delivered to address emergencies abroad fell 5 percent," the Washington Independent reports.

3 Oct 2009

Advanced Liquid Logic awarded an NIAID contract to develop a rapid HIV diagnostic device

Advanced Liquid Logic announced today that it has received a large, four-year contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for the development of a rapid, point-of-care, diagnostic device for the detection of HIV in low resource settings.

3 Oct 2009

New study underscores lack of appropriate government action to ensure safety of vaccines

A new study in the leading scientific journal NeuroToxicology lends further credence to parents and scientists concerned about an increasingly aggressive childhood vaccine schedule and toxic vaccine components.

2 Oct 2009

Opinions: Bridging the divide to stop the spread of HIV; ending future world hunger

"With less than half the people who need treatment having access and with each day more people becoming infected with HIV than are started on treatment, we are mortgaging our future. But we are also exposing a fundamental social injustice - between the privileged and the forsaken - a divide we can bridge," Michael Sidibe, the executive director of UNAIDS, writes in a Daily Nation opinion piece.

1 Oct 2009

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc. (OTCBB: ADXS), the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in three (3) of the thirteen (13) evaluable patients treated with Advaxis’ therapeutic cancer vaccine, indicating the possibility of persistent immune protection.

1 Oct 2009

Diamyd Medical signs agreement with Inclinix to conduct global Phase III program

Diamyd Medical announces today that the company has signed an agreement with Inclinix Inc., North Carolina, for accelerated recruitment of children and adolescents recently diagnosed with type 1 diabetes in the US Phase III study of the diabetes vaccine Diamyd(R).

1 Oct 2009

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

The FDA has approved the first set of vaccines aimed at preventing H1N1 infection after an approval process of less than four months. Cutting Edge Information is currently analyzing the lessons learned that may emerge for both the Food and Drug Administration (FDA) and life science firms after this crisis experience.

1 Oct 2009

Vaccine News and Research

Latest Vaccine News and Research

American Lung Association kicks off its Faces of Influenza campaign in Miami

HSPH's survey on H1N1 vaccines

Publix Pharmacies offers to compound Tamiflu into an oral suspension for no additional charge

Surgical masks appear as effective as N95 respirators against influenza: Study

Chinese government places second purchase order for Sinovac Biotech's H1N1 vaccine

Vaccinate children with H1N1 flu vaccine to control swine flu: UAB

90% of public support H1N1 vaccination for health care workers

DelSite's assests acquired by Nanotherapeutics

Face mask: A vital tool in fighting H1N1

Interim results of Sanofi Pasteur's Influenza A (H1N1) 2009 Monovalent Vaccine clinical trials announced

Researchers screen decades-old frozen infant stool samples to detect norovirus

EMEA grants positive opinion for Baxter's CELVAPAN H1N1 pandemic vaccine

First U.S. patients could receive H1N1 vaccine next week

Also in Global Health news: U.S. food aid declines; agriculture in Zimbabwe; U.S.-backed ITN network; reducing maternal mortality; DNDI expands; healthcare in Congo

Advanced Liquid Logic awarded an NIAID contract to develop a rapid HIV diagnostic device

New study underscores lack of appropriate government action to ensure safety of vaccines

Opinions: Bridging the divide to stop the spread of HIV; ending future world hunger

Advaxis announces Phase I trial results of its ADXS11-001 therapeutic cancer vaccine

Diamyd Medical signs agreement with Inclinix to conduct global Phase III program

Cutting Edge Information hopes to see ill patients have speedier access to potential cures

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in